Sign In
Buy DXCM
$82.66
-4.28 (-4.92%)
At Close: Aug 05, 2026
Lost Money on DexCom, Inc. (DXCM)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky
09:00am, Tuesday, 30'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 30, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of DexCom, Inc. ("DexCom") (NASDAQ:DXCM) concerning possible violations of federa
DXCM Investors Can Participate In The DexCom, Inc. Securities Fraud Investigation With The Schall Law Firm
08:30am, Tuesday, 30'th Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of DexCom, Inc. ("De
Shareholder Rights Advocates at Levi & Korsinsky Investigate DexCom, Inc. (DXCM) Regarding Possible Securities Fraud Violations
06:24am, Tuesday, 30'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 30, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of DexCom, Inc. ("DexCom") (NASDAQ:DXCM) concerning possible violations of federa
NEW YORK, NY / ACCESSWIRE / July 30, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into DexCom, Inc. (NASDAQ:DXCM) for potential violations of the federal se
DexCom Stock Plunged Over 40% Last Week. Are Eli Lilly's and Novo Nordisk's Drugs to Blame?
05:48am, Tuesday, 30'th Jul 2024
DexCom stock crashed after the company reported disappointing Q2 results and cut its full-year guidance. This performance raised questions about the potential impact of GLP-1 drugs on DexCom's busines
NEW YORK, NY / ACCESSWIRE / July 29, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of DexCom, Inc. ("DexCom") (NASDAQ:DXCM) concerning possible violations of federa
SAN FRANCISCO, July 29, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges DexCom, Inc. (NASDAQ: DXCM) investors who suffered substantial losses to submit your losses now . The firm also encourages persons
DexCom, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by DexCom (DXCM)
03:00pm, Monday, 29'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 29, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of DexCom, Inc. ("DexCom") (NASDAQ:DXCM) concerning possible violations of federa
DXCM Investors Can Join The DexCom, Inc. Securities Fraud Investigation With The Schall Law Firm
02:45pm, Monday, 29'th Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of DexCom, Inc. ("De
DXCM ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of DexCom, Inc. Shareholders Who Lost Money
11:45am, Monday, 29'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 29, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of DexCom, Inc. ("DexCom") (NASDAQ:DXCM) concerning possible violations of federa
Johnson Fistel Begins Investigation into DexCom Following a Significant Drop in the Company's Stock
11:20am, Monday, 29'th Jul 2024
SAN DIEGO , July 29, 2024 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether DexCom, Inc. (NASDAQ: DXCM) or any of its executive officers or others violated secu
Worried About A Looming 40% Crash? It's Here Already For 12 Stocks
08:00am, Monday, 29'th Jul 2024
You don't have to wait any longer for a great crash to arrive. Some S&P 500 stocks are already in a world of hurt.
NEW YORK, NY / ACCESSWIRE / July 29, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of DexCom, Inc. ("DexCom") (NASDAQ:DXCM) concerning possible violations of federa
NEW YORK, July 29, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into DexCom, Inc. (NASDAQ: DXCM) for potential violations of the federal s
Is Beaten-Down Dexcom Stock a Buy on the Dip?
05:54am, Monday, 29'th Jul 2024
Dexcom reported second-quarter results on Friday, July 26. Management lowered its forward revenue outlook because of unexpected challenges with its new glucose monitoring device.
